NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	22/05/2020
Target sample size	360
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy confirmatory
Secondary Outcome	exploratory efficacy efficacy exploratory efficacy exploratory efficacy exploratory exploratory efficacy safety exploratory safety exploratory safety exploratory safety exploratory

Key inclusion & exclusion criteria

Age minimum	>= 2age old
Age maximum	<= 55age old
Gender	Both
Include criteria
Exclude criteria